UK set on resolving standoff with big pharma, science minister says
The UK government must increase NHS medicines spending and resolve tensions with pharmaceutical firms after major drugmakers cancelled nearly 2bn of planned UK investments.
Big pharma will stop investing in UK, warns eminent scientist Sir John Bell
Major pharmaceutical companies are withdrawing planned UK investment due to pricing pressures, undervaluation of innovative medicines, and reduced NHS pharmaceutical spending.